Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cross-Reactivity, Epitope Spreading, and De Novo Immune Stimulation Are Possible Mechanisms of Cross-Protection of Nonvaccine Human Papillomavirus (HPV) Types in Recipients of HPV Therapeutic Vaccines.
Nakagawa M, Greenfield W, Moerman-Herzog A, Coleman HN. Nakagawa M, et al. Among authors: greenfield w. Clin Vaccine Immunol. 2015 Jul;22(7):679-87. doi: 10.1128/CVI.00149-15. Epub 2015 May 6. Clin Vaccine Immunol. 2015. PMID: 25947147 Free PMC article. Review.
A novel use of a statewide telecolposcopy network for recruitment of participants in a Phase I clinical trial of a human papillomavirus therapeutic vaccine.
Stratton SL, Spencer HJ, Greenfield WW, Low G, Hitt WC, Quick CM, Jeffus SK, Blackmon V, Nakagawa M. Stratton SL, et al. Among authors: greenfield ww. Clin Trials. 2015 Jun;12(3):199-204. doi: 10.1177/1740774514566333. Epub 2015 Jan 9. Clin Trials. 2015. PMID: 25576067 Free PMC article. Clinical Trial.
A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with Candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3.
Greenfield WW, Stratton SL, Myrick RS, Vaughn R, Donnalley LM, Coleman HN, Mercado M, Moerman-Herzog AM, Spencer HJ, Andrews-Collins NR, Hitt WC, Low GM, Manning NA, McKelvey SS, Smith D, Smith MV, Phillips AM, Quick CM, Jeffus SK, Hutchins LF, Nakagawa M. Greenfield WW, et al. Oncoimmunology. 2015 May 27;4(10):e1031439. doi: 10.1080/2162402X.2015.1031439. eCollection 2015 Oct. Oncoimmunology. 2015. PMID: 26451301 Free PMC article.
Human papillomavirus type 16 viral load is decreased following a therapeutic vaccination.
Coleman HN, Greenfield WW, Stratton SL, Vaughn R, Kieber A, Moerman-Herzog AM, Spencer HJ, Hitt WC, Quick CM, Hutchins LF, Mackintosh SG, Edmondson RD, Erickson SW, Nakagawa M. Coleman HN, et al. Among authors: greenfield ww. Cancer Immunol Immunother. 2016 May;65(5):563-73. doi: 10.1007/s00262-016-1821-x. Epub 2016 Mar 15. Cancer Immunol Immunother. 2016. PMID: 26980480 Free PMC article. Clinical Trial.
83 results